Ristamäki R - Search Results

1

Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.

Joensuu H, Ristamäki R, Söderström KO, Jalkanen S. Joensuu H, et al. Among authors: ristamaki r. J Clin Oncol. 1994 Oct;12(10):2167-75. doi: 10.1200/JCO.1994.12.10.2167. J Clin Oncol. 1994. PMID: 7931487 Clinical Trial.

2

Serum CD44 in malignant lymphoma: an association with treatment response.

Ristamäki R, Joensuu H, Salmi M, Jalkanen S. Ristamäki R, et al. Blood. 1994 Jul 1;84(1):238-43. Blood. 1994. PMID: 7517210 Free article.

3

CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.

Ristamäki R, Joensuu H, Söderström KO, Jalkanen S. Ristamäki R, et al. J Pathol. 1995 Jul;176(3):259-67. doi: 10.1002/path.1711760308. J Pathol. 1995. PMID: 7545748

4

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

Joensuu H, Ristamäki R, Klemi PJ, Jalkanen S. Joensuu H, et al. Among authors: ristamaki r. Br J Cancer. 1993 Aug;68(2):428-32. doi: 10.1038/bjc.1993.354. Br J Cancer. 1993. PMID: 8347502 Free PMC article.

5

Does soluble CD44 reflect the clinical behavior of human cancer?

Ristamäki R, Joensuu H, Jalkanen S. Ristamäki R, et al. Curr Top Microbiol Immunol. 1996;213 ( Pt 3):155-66. doi: 10.1007/978-3-642-80071-9_10. Curr Top Microbiol Immunol. 1996. PMID: 8815003 Review. No abstract available.

6

Origin and function of circulating CD44 in non-Hodgkin's lymphoma.

Ristämaki R, Joensuu H, Grön-Virta K, Salmi M, Jalkanen S. Ristämaki R, et al. J Immunol. 1997 Mar 15;158(6):3000-8. J Immunol. 1997. PMID: 9058839

7

Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma.

Ristamäki R, Joensuu H, Lappalainen K, Teerenhovi L, Jalkanen S. Ristamäki R, et al. Blood. 1997 Nov 15;90(10):4039-45. Blood. 1997. PMID: 9354673 Free article.

8

Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.

Villikka K, Muhonen T, Ristamäki R, Teerenhovi L, Joensuu H. Villikka K, et al. Among authors: ristamaki r. Acta Oncol. 1997;36(6):619-24. doi: 10.3109/02841869709001325. Acta Oncol. 1997. PMID: 9408153 Clinical Trial.

9

Clinical significance of circulating CD44 in non-Hodgkin's lymphoma.

Ristamäki R, Joensuu H, Hagberg H, Kalkner KM, Jalkanen S. Ristamäki R, et al. Int J Cancer. 1998 Jun 19;79(3):221-5. doi: 10.1002/(sici)1097-0215(19980619)79:3<221::aid-ijc2>3.0.co;2-r. Int J Cancer. 1998. PMID: 9645341 Free article.

10

Serum CD44 in non-Hodgkin's lymphoma.

Ristamäki R, Joensuu H, Jalkanen S. Ristamäki R, et al. Leuk Lymphoma. 1999 May;33(5-6):433-40. doi: 10.3109/10428199909058448. Leuk Lymphoma. 1999. PMID: 10342571 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page